GB2360845A - Measuring gastric emptying - Google Patents

Measuring gastric emptying Download PDF

Info

Publication number
GB2360845A
GB2360845A GB0007315A GB0007315A GB2360845A GB 2360845 A GB2360845 A GB 2360845A GB 0007315 A GB0007315 A GB 0007315A GB 0007315 A GB0007315 A GB 0007315A GB 2360845 A GB2360845 A GB 2360845A
Authority
GB
United Kingdom
Prior art keywords
test
premix
gastric emptying
labeled
meal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0007315A
Other versions
GB0007315D0 (en
Inventor
Yvo Ghoos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KU Leuven Research and Development
Original Assignee
KU Leuven Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KU Leuven Research and Development filed Critical KU Leuven Research and Development
Priority to GB0007315A priority Critical patent/GB2360845A/en
Publication of GB0007315D0 publication Critical patent/GB0007315D0/en
Priority to PCT/BE2001/000050 priority patent/WO2001072342A1/en
Priority to AU2001243965A priority patent/AU2001243965A1/en
Publication of GB2360845A publication Critical patent/GB2360845A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • A61K49/1815Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206Administration of radioactive gases, aerosols or breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1296Radioactive food, e.g. chocolates, drinks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Abstract

A method and kit for measuring gastric emptying in a test subject are characterised by using a premix of a C-13 labelled compound ,e.g. octanoic acid, and typically freeze dried egg yolk. The premix is blended with water to form a batter which is baked into a meal for ingestion by the test subject and the C-13 labelled carbon dioxide present in exhaled breath samples measured as an indicator of gastric emptying. Also claimed is a process for preparing the premix e.g. using a C-13 labelled fatty acid and freeze dried egg yolk and use of the premix to develop a medicine that alters gastrointestinal motilty or transit or to investigate or formulate a diet.

Description

Gastric emptying test-kit and method of testing gastric emptying of solid meal FIELD OF THE INVENTION This invention generally relates to a kit for testing gastric emptying of solids and more specifically to stable isotope labeled of medium chain fatty acid incorporated in a dry premix. More specifically it involves the improvement of the classic 1'C-octanoic acid egg-omelet breath test, wherein the<B>13C</B> tracer had to be incorporated in a fresh test meal and the yolk phase and egg white phases had initially to be separated during baking of the omelet. In present invention it is surprisingly found that a dry premix can be prepared, comprising a mixture of the labeled egg yolk and egg white, for easy instant and in situ preparation of a test meal according to a standardized method and for reliable diagnosis of solid phase gastric emptying by monitoring the appearance of "CO., in breath.
BACKGROUND OF THE INVENTION Digestion of all foods in humans and other mammals begins in the stomach where both solid and liquid matter is mixed with gastric juices that are secreted by the stomach walls. The gastric juice is predominately hydrochloric acid, but also includes enzymes that break down food constituents so that they can be absorbed and used. The contents of the stomach are emptied into the small intestine via the pyloric sphincter, which opens and closes to release pulses of the mixed solids and liquids. The rate of such emptying is regulated by this sphincter. The rate is determined by the caloric content of the meal. The higher the caloric content, the lower the rate of discharge. In addition, the solid phase of the food must undergo reduction in particle size, which is caused by contractions of the stomach walls until a particle size of about 1 mm in diameter is attained.
A disorder in the rate of gastric emptying can result either in too rapid or in delayed emptying. When the rate is accelerated the food is "dumped" into the small intestine prematurely. When delayed, the time required to empty the stomach is excessive. Delayed gastric emptying often is encountered in diabetic patents and may be associated with abdominal pain, cramping and bloating. Even healthy people often notice subjective gastric symptoms (sinking feelings, heartburn, anorexia, etc.) in the everyday life. It has been estimated that symptoms of functional gastrointestinal disorders, those without noticeable structural, infectious, or biochemical cause, occur to some degree in nearly on quarter of all individuals who are otherwise healthy. Gastric symptoms are also caused by stress, overeating, excessive intake of alcoholic drinks and intake of drugs. Additional major causes of the complaints about the digestive tracts include maldigestion, chronic gastritis, delayed gastric emptying after meals, gastric hyperacidity and peptic ulcers which bring about subjective symptoms such as abdominal swelling feelings, unpleasantness in the upper abdomen, anorexia, heartburn and belching (eructation). These functional disorders, often caused by delayed gastric emptying, require an objective, practical and efficient tests to measure gastric emptying.
In previous studies (1,2) it has been demonstrated that gastric emptying can be measured accurately by means of the 13C,octanoic acid egg-omelet breath test. The 13C,tracer is incorporated in a test meal, which consists of an egg omelet and three slices of breath. The test represents real advantage over the radiolabeled test meal methods to measure gastric emptying, i.e. radioscintigraphy, as it can be applied in all patients as no exposure to radioactivity is involved. Furthermore the test is simple to be performed by the patient, and several tests can be executed in the same time. By this, it represents cost-savings of instrumentation and personnel also. The use of the above non-radioactive substrates has been validated against the prior radiological methods with high correlation (1,3).
With the breath test with 13C-octanoic acid "standard" egg-omelet it has been demonstrated that postgastric processing of 13C-octanoic acid until 13C02 exhalation occurs very rapidly, with minimal intersubject variability. This is due to the very rapid absorption from the small intestine, to quick transport to the liver (no mucosal esterification, no incorporation in chylomicrons (3, 6, - 8), and to a ready and almost complete oxidation to 13C02 in the liver (no requirement for carnitine to cross the double mitochondria) membrane (9,10)). Therefore, gastric emptying of the meal can be considered a limiting step in 13C02 excretion after ingestion of a 13C-octanoic acid labelled solid meal. Also an average function can be used to describe the postgastric processing of octanoic acid. Metabolism of octanoic acid remains unaltered not only in healthy volunteers but also in other circumstances, as has been shown for insulin-dependent diabetes mellitus (11) or after administration of octreotide (12) <B>13</B> C-octanoic had initially been selected for testing gastric emptying by a breath test since it has been shown for a long time that octanoic acid, an eight-carbon fatty acid found in dietary fats, is rapidly absorbed from the intestine and carried to the liver via the portal venous system, where it is rapidly and completely oxidised. For testing the gastric emptying of the solid food by the non-radioactive markers, 13C-octanoic acid has, however, to be ingested in a freshly baked egg sandwich. The physician has thus to prepare the meal before the test administration. The nature of such a procedure makes the development of a standard solid- phase emptying protocol or procedure difficult, and hinders the commercial development of an office-based procedure. A prepared and pre-packaged test kit would have the advantage of storage at room temperature, instant availability and ease of transportation to the place of an experimental set up for in situ diagnosis. However, this development was hindered by the fact that as a rule the egg yolk homogenized with 13C-octanioc acid had to be baked separately from the egg white to ensure a firm retention of the label in the solid phase of the meal (1).
To overcome the problems mentioned above with the current 13C,octanoic acid breath test and to avoid the use of radioactive tracer, Klein Peter D, 1989 (4) proposed the use of single cell organisms as markers for solid-phase meals. The intrinsically labeled single cell marker organisms, proteins, lipids or carbohydrates were incorporated into a baked product that is ingested by the patient. The product containing the marker organisms was a biscuit having an edible photosynthetic alga therein, such as Spirulina platensis. The alga had to be photosynthetic and had to be grown in an atmosphere of about 99% 13C02, so that as a consequence of the photosynthetic process all carbon atoms contained in the alga would be <B>13C</B> . The labeled single cell marker organisms were then mixed in a batter with proteins, lipids or carbohydrates and were baked into a biscuit for ingestion by the patient. Although this techniques could overcome the disadvantages of inconvenience and standardization related to fresh meal preparation and to egg white I egg yolk separation in the classic egg-omelet breath test, it still requires a controllable alga culture process in a photosynthetic reaction tank with nutrient solutions and 13 C02 gas input. The inconsistency of such life process may affect the reliability of the final test product.
Furthermore, growing photosynthetic alga in an air atmosphere enriched with `3C02 atmosphere will result in the incorporation 13C atom in a variety of functional and structural proteins, fat and carbohydrate macromolecules. Because of their varied chemistry and physical form the rate and extent to which the different types of nutrients are digested in and absorbed from the small intestine and the metabolism of the different fatty acids, amino acids or sugars will vary.
The 13C02 breath test is an indirect measurement of gastric emptying since the 13C02 appearance curve reflects the sum influence of gastric emptying, digestion, absorption and metabolism. The availability, absorption and metabolic processing of a labeled compound must thus be fast and reproducible to obtain only gastric emptying as rate limiting step. This is obtained with octanoic acid in particular and likely with other medium chain fatty acids, since they are absorbed by the small intestine and are rapidly transported to the liver bound to serum albumin for free entering in the mitochondria and fast oxidation to C02. These features make medium chain fatty acids, on condition that they are not freely available in the stomach, suitable for measuring gastric emptying. The proteins of single cell organisms, however will undergo a complex series of degradative processes which are elucidated by the hydrolytic enzymes originating from the stomach, pancreas and the brush border of the small intestine. Pancreatic digestion plays a critical role in the overall protein assimilation. Since it has been previously been demonstrated by a 13C-labeled protein meal ingestion and 13C0 exhalation, that protein assimilation and not the metabolism of the amino acids is the rate limiting step, 13C-labeled protein test can be considered a promising test for the evaluation of the digestibility of protein and the evaluation and the follow up of exocrine pancreatic function (13) but not for measurement of gastric emptying, especially not for patients with malabsorption symptoms. For instance with 13C egg white, generally considered to be highly digestible, there exists in a breath test a very good correlation between the 13C02 production and the pancreatic trypsin output in the duodenum (13). Nevertheless, not all egg white proteins are well absorbed. Some undergo additional fermentation in the colon, which results in COz release, origination from bacterial metabolism (20).
There is thus a need for a safe, practical, accurate and ease to standardize test to diagnosis of gastric emptying of solids. This invention provides these features by improvement the classic 13C-octanoic acid egg-omelet test (in use since the early nineties) to a test kit with a dry 13C octanoic acid premix. This was a challenge since in the classic egg-omelet test 13C octanoic acid enriched yolk and egg white has to baked separately to avoid that 13C is released and absorbed in the stomach. In the kit of present invention, both fractions of the egg, i.e. egg white and labeled yolk, are in the same powder mix, without loosing the diagnostic properties. SUMMARY OF THE INVENTION For the classic octanoic acid breath test, 13C,tracer is incorporated in a test meal, which consists of an egg omelet and three slices of bread. This meal has to be prepared just before the test starts. By consequence the patients have to come to the laboratory unit, where the test meal is served. During 4 hours the patient stays at the laboratory and is asked to blow in a tube every 15 minutes.
Present invention involves the development of a test-kit that can be send as such to other hospitals, and even the patient can take the test-kit at home where the test can be executed at time, convenient for the patient. Until now this was not possible for the 13C,octanoic acid breath test, since the present test meal, i.e. egg omelet had to be prepared freshly by homogenizing of 13C-octanoic acid in yolk and baking it separately from the egg white just before the test started (1,2, 3, 5, 12 - 19) By this invention we present for the first time the test meal as prepackaged food in such a way that a test-kit can be composed, which allows the measurement of gastric emptying out of the hospital with results, equally good as the "standard" egg-omelet meal.
The present meal, containing the '3C,octanoic acid, is a powder, to which water is added to obtain a batter. The batter allows to bake a pancake, which upon digestion is equally reliable as the omelet to measure gastric emptying by 13C02 breath test. The pancake-powder has been prepared following the hygienic procedures, common in food industries. It is packed water- free, kept under nitrogen and wrapped in aluminum foil. The test-kit is further composed of test tubes and all information to execute the test properly.
Advantages are double:<I>first,</I> the patients are not obliged to come to the hospital; upon instructions the test can even be executed at home.<I>Second,</I> it is guaranteed that the powder is kept fresh for more than one year.
In the present study we prove that the novel test meal (pancake-powder) is equally good as the omelet meal to measure gastric emptying by '3 C02 breath test.
EXAMPLES Example 1 Production of the pre-packed test kit <U>Test meal:</U> The pancake-powder is composed per unit pancake in the following way: In laboratory conditions, per 8.6 g egg yolk 100 microliter `3C,octanoic acid is added and mixed for homogeneous distribution of the tracer in the yolk-material, consequently this is lyophilized. Consequently this is mixed with 3.75 g lyophilized egg white, 17 g wheat flour and 3 g milk powder. A total weight of the powder is 32.35 g; it represents 179.1 kcal. The premix is used in this amounts to prepare one pancake. The same premix has, however, also been prepared on lager scale by Ovofood, Herk-de-Stad, Belgium. An aluminum sachet with premix in the amount to prepare one pancake makes part of the test kit.
To make the pancake 32.35 g of the powder premix is suspended in 70 ml of water, and the batter is baked in the pan by addition of 3 g fat. The pancake is served with an additional amount of 5 g (beet)sugar as sweetener. Total caloric intake is 225.1 kcal.
Example 2 Measuring gastric emptying of the solid phase with the pre-packed test kit <U>Subjects:</U> There are four groups of normal individuals involved in the comparative study: group A: the individuals, as described in the publication (1) group B: the individuals as described in ref 2.
group C: sixteen normal individuals took a pancake, of which the powder has been prepared by the laboratory personnel. _ group D: eight normal individuals took a pancake, of which the premix powder has been prepared in an industrial manner by Ovofood, Herk-de-Stad, Belgium.
Every patient receives 1 plastic straw and 18 tubes with screw cap from the test kit. The test is preferably executed in the morning (at starvation). The patients stay in rest during the test, although a slow walk is permitted. They stay in upright position the first two hours of the test; after that time more conformable position may be adopted, but never they are allowed to lie down.
To provide a breath sample, the patients keep the straw at the bottom of the tube, they inhale deeply and expirate 5 seconds through the straw. The tube is immediately closed thereafter. The test is performed as follows: Before ingestion of the pancake the patients blow in the first vial and half a minute thereafter in vial 2. The pancake is eaten within 10 minutes. As drink (150-m1) only water, coffee or tea is allowed. Coffee or tea can be creamed and/or sweetened, but not with cane sugar. A soft drink or fruit juice is not allowed. During the test, small quantities (20 ml) of drinks can be taken, just to cut thirst. 15 minutes after the end of the meal the patients blow in the next tube. 30 minutes after the end of the meal the patients blow into tube 4. Every 15 minutes thereafter the patients blow in the next tube, up to 4 hours (240 min). The test end after 4 hours.
<U>Analysis of the tubes</U> 13C contents in breath is determined by on line gas chromatographic purification-isotope ratio mass spectrometry (ABCA; Europe Scientific). The 8 value given by the isotope ratio mass spectrometry are converted to percentage 13C recovery of the initial amount administered per hour (% dose 13C/h) according to calculations described in detail by Ghoos et al (5) <U>Statistics:</U> Analysis of variance on average t1/2 - value is done (ANOVA-test). The level of significance is set at p < 0.05. The program used was SAS/STAT release 6.03 Edition 1 (SAS institute Inc. Raleigh, NC) <U>Results:</U> In the following table the values of test results are shown, following the four groups
Table I: group A group B group C group D n = 42 10 16 8 t 1/2 (mean) 72 68 80 71 sd 22 27 21 18 + 2 sd 118 122 122 <B>1</B>07 - 2 sd 20 14 38 35 <U>Statistical evaluation:</U> No significance level was reached.
DISCUSSION By comparative studies is has been demonstrated that there is no statistical difference when the omelet meal is replaced by the pancake to measure gastric emptying by 13C02 breath test. The pancake meal shows great advantages over the omelet meal. It is no longer necessary that the patient presents to the hospital to execute the breath test. Even the test can be done at home, when the patient is properly instructed. The breath samples have to be sent to the analytical unit, and the test results are sent to the medical doctor, who informs the patient. By this method it will be easier in the future to study the influence of pharmacological modulation of gastric emptying as the test meal is uniform for all individuals involved in the study, and as the test can be executed over the world, wherever wanted. As the powder keeps fresh over a long time, clinical investigations and pharmacological effects can be planned over a widespread period. This meal enables to present the 13C02 breath test for gastric emptying as a test-kit, which makes the whole procedure uniform and repeatable for all persons, to whom the test can be applied.
In <U>conclusion</U>: The proposed method, which gives results similar as the omelet method, can be considered very reliable to measure gastric emptying of solids, as the egg omelet method provides an excellent correlation between gastric half-emptying time (r= 0.98) and log phase (r=0.85), determined via 13C02 breath test and radioscintigraphy, which is classically considered to be a reference method (3). The pancake method to study gastric emptying by means of the 13C02 breath test offers great advantage over other test meals. It is foreseen that the proposed pancake test meal will have great acceptance in clinical practice and research. <U>Fields of applications</U>: The presented test can be applied in all categories of the population, children, adults, pregnant women, elderly people. <I>in clinical diagnostic context:</I> Measuring gastric emptying in children, adults and elderly people in the hospital. The test can be sent to other hospitals as a test-kit , and can even be taken at home to have the test done by. the patient at the time, which is the most convenient for him(her).
<I>in research context:</I> - in clinical research: the test can be considered reference method to demonstrate gastric emptying in different pathological conditions. To the presented test meal (pancake powder) other tracer molecules can be added to study gastrointestinal functions, other than gastric emptying, e.g. assimilation of carbohydrates, lipids, proteins, oro-cecal transit, bacterial overgrowth or/and fermentation processes in the colon.
- in pharmaceutical research: the test can be taken as reference method for testing and developing drugs, affecting gastrointestinal motility and transit.
- in nutritional research: the test can also be taken as reference method to demonstrate gastric emptying of food formula.
<U>References</U> <I>1)</I> Ghoos YF, Maes <I>BD,</I> Geypens BJ, Mys <I>G,</I> Hiele <I>MI,</I> Rutgeerts PJ, Vantrappen <I>G</I> <I>Measurement of gastric emptying rate of solids by means of a carbon-labeled</I> octanoic <I>acid breath test.</I> Gastroenterology<I>1993</I> Jun;104(6):1640-7 <I>2)</I> Maes B.D., Ghoos YF., Geypens B.J., Mys <I>G.,</I> Hiele MI, Rutgeerts P.J., Vantrappen <I>G.</I> <I>Combined carbon</I> 13-glycine%arbon-14-octanoic <I>acid breath test to monitor gastric</I> <I>emptying rates of liquids and solids. J.</I> Nucl. Med. <I>35: 824-831, 1994.</I>
<I>3)</I> Maes <I>B.,</I> Mys <I>G.,</I> Geypens <I>B.,</I> Evenepoel <I>P.,</I> Ghoos <I>Y.,</I> Rutgeerts <I>P.: Gastric emptying</I> flow <I>curves separated from carbon-labeled</I> octanoic <I>acid breath test results. Am. J.</I> Physiol., <I>275, G169 -</I> G175,1998 <I>4) Klein Peter D., Measurement of gastric</I> emptying, US5707602, CA2239018, EP0889739, <I>W09735622</I> <I>5)</I> Ghoos <I>Y,</I> Geypens <I>B.,</I> Maes <I>B. et al. Breath tests in gastric emptying and transit studies:</I> <I>technical aspects of</I> 13C02-breath <I>tests. In: Janssens J,</I> ed. <I>Progress in understanding</I> <I>and management of gastrointestinal</I> motility <I>disorders. K.</I> ULeuven: <I>Belgium,<B>1993: 169</B></I> <B><I>-80.</I></B>
<I>6)</I> Iber <I>F. Relative rates of metabolism of</I> MCT, LCT <I>and ethanol in man. In:</I> Mittelkettige <I>in</I> <I>der</I> Didt, <I>edited by H.</I> Kaunitz, <I>Lang and W.</I> Fekl. <I>Berlin: Z.</I> Erndhrungswiss, <I>1974,</I> vol. <I>17, p 9-l6.</I> <I>7) Mishkin, S. L. Stein, Z.</I> Gatmaitan, <I>and 1. M. Arias. The binding of fatty acids to</I> cytoplasmatic <I>proteins: binding to Z protein in liver and other</I> tissies <I>of rat.</I> Biochem. Biophys. <I>Res.</I> Commun. <I>83:479 - 485, 1978.</I>
<I>8)</I> Ockner, <I>R. K, J. A. Manning,</I> R.B.Poppenhausen <I>and W K Ho A binding protein for</I> <I>fatty acids in</I> cytosol <I>of intestinal</I> mucosa, <I>liver, myocardium and other tissues. Science</I> <I>177:</I> 56 - 58,<I>1972.</I>
<I>9) Bremer J.</I> Carnitine <I>and its role in fatty acid metabolism. Trends</I> Biochem. Sci. <I>2: 207-</I> <I>209, 1980.</I>
<I>10)</I> Scheig, <I>R. Hepatic metabolism of medium chain fatty acids. In: Medium Chain</I> Triglycerides, <I>edited by</I> J.R. <I>Senior. Philadelphia, PA:</I> Univeristy <I>of</I> Pennsyivania, <I>1968,</I> <I>p. 39 - 49.</I>
<I>11)</I> Maes, B.D. <I>Measurement of gastric emptying using dynamic breath</I> analysis,<I>edited by B.</I> Maes. <I>Leuven, Belgium:</I> Acco <I>1994.</I>
<I>12)</I> Maes, B.D., <I>Y. F.</I> Ghoos, B.J. Geypens, M.L Hiele, <I>and</I> P.J. Rutgeerts. Inflence <I>of</I> octreotide <I>on gastric emptying of solids and liquids in normal healthy volunteers.</I> <I>Aliment.</I> Pharmacol. Ther. <I>9: 11-18, 1995.</I>
<I>13)</I> Evenepoel <I>P., M</I> Hielle, Geypens <I>B.,</I> Geboes <I>K. P.,</I> Rutgeerts <I>P. and</I> Ghoos <I>Y.</I> 13C-egg <I>white breath test: a</I> non-invaisve <I>test of</I> pancratic trypsin <I>activity in the small intestine.</I> <I>Gut, January 2000, Vol 46, No 1, p 52-57.</I>
<I>14) Van Den</I> Driessche <I>M,</I> Peeters <I>K,</I> Marien <I>P,</I> Ghoos <I>Y,</I> Devlieger <I>H,</I> Veereman-Wauters <I>G</I> <I>Gastric emptying in formula fed and breast fed infants measured with the</I> 13C-octanoic <I>acid breath test. J</I> Pediatr Gastroenterol Nutr. <I>1999</I> Jul; <I>29(1): 46-51.</I>
<I>15)</I> Maes <I>BD,</I> Hiele <I>MI,</I> Geypens BJ, Ghoos YF, Rutgeerts PJ <I>Gastric emptying of the liquid,</I> <I>solid and oil phase of a meal in normal volunteers and patients with</I> Billroth <I>11</I> gastrojejunostomy. Eur <I>J</I> Clin <I>Invest 1998</I> Mar,-28(3):197-204 <I>16)</I> Maes <I>BD,</I> Geypens BJ, Ghoos YF, Hiele <I>MI,</I> Rutgeerts PJ 13C-Octanoic <I>acid breath test for gastric emptying rate of solids.</I> Gastroenterology<I>1998</I> Apr;114(4): <I>856-9</I> <I>17)</I> Pfaffenbach <I>B, Wegener M,</I> Adamek RJ, Wissuwa <I>H,</I> Schaffstein <I>J,</I> Aygen <I>S,</I> Hennemann <I>O. Non-invasive 13C</I> octanoic <I>acid breath test for measuring stomach emptying of a</I> <I>solid test</I> meal--correlation <I>with scintigraphy in diabetic patients and reproducibility in</I> <I>healthy</I> probands. Z Gastroenterol <I>1995 Mar; 33(3):141-5</I> <I>18)</I> Maes <I>BD,</I> Ghoos YF Rutgeerts PJ, Hiele <I>MI,</I> Geypens <I>B,</I> Vantrappen <I>G</I> [*C]octanoic <I>acid breath test to measure gastric emptying rate of solids.</I> Dig Dis Sci <I>1994</I> Dec; <I>39(12</I> Suppl):104S-106S <I>19)</I> Maes <I>BD,</I> Hiele <I>Ml,</I> Geypens BJ, Rutgeerts PJ Ghoos YF Vantrappen <I>G</I> Pharmacological <I>modulation of gastric emptying rate of solids as measured by the</I> <I>carbon labelled</I> octanoic <I>acid breath test:</I> influence <I>of</I> erythromycin <I>and</I> propantheline. Gut<I>1994 Mar; 35(3): 333-7</I> <I>20)</I> Evenepeol <I>P., Claus D.,</I> Geypens <I>B.,</I> Hiele <I>M.,</I> Geboes <I>K.,</I> Rutgeerts <I>P and</I> Ghoos <I>Y.</I> <I>Amount and fate of egg protein escaping assimilation in the small intestine of humans.</I> <I>AM. J.</I> Physiol. <I>277 G935- G943,<B>1999</B></I>

Claims (12)

  1. CLAIMS 1. A method of diagnosing gastric emptying of the solid phase in a subject, which comprises the steps of mixing water with 13C labeled molecules in said a powdered premix, baking said the resulting batter into a solid meal, ingesting said solid meal and measuring 3C02 in breath samples.
  2. 2. The method in accordance with Claim 1 wherein the 13C labeled substrate is a fatty acid.
  3. 3. The method in accordance with Claim 1 wherein the 13C labeled substrate is a medium chain fatty acid.
  4. 4. The method in accordance with Claim 1 wherein the 13C fatty acid is an octanoic acid.
  5. 5. A test kit for carrying out the method of any preceding claims comprising a prepackaged premix.
  6. 6. The test kit of claim 5 further comprising tubes with cap and comprising at least 1 straw for blowing.
  7. 7. A process for producing said premix of any of the claims 1 to 6 wherein the 13C labeled fraction is obtainable from freeze dried egg yolk.
  8. 8. A process for producing said premix of any of the claims 1 to 6 wherein the 13C labeled fraction is obtainable from spray dried egg yolk.
  9. 9. The process of the claims 7 or 8, wherein the powdered premix comprises a mixture of said labeled egg yolk with powdered egg white.
  10. 10. The process of the claims 7 or 8, wherein the powdered premix comprises a mixture of said labeled egg yolk with powdered egg white, wheat flour and milk powder in suitable amounts to prepare a solid meal.
  11. 11. Use of the premix of any of the claims 1 to 10 to test or develop a medicine that alter gastrointestinal motility or gastrointestinal transit.
  12. 12. Use of the premix of any of the claims 1 to 10 to investigate or formulate a diet.
GB0007315A 2000-03-27 2000-03-27 Measuring gastric emptying Withdrawn GB2360845A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0007315A GB2360845A (en) 2000-03-27 2000-03-27 Measuring gastric emptying
PCT/BE2001/000050 WO2001072342A1 (en) 2000-03-27 2001-03-26 Gastric emptying test-kit and method of testing gastric emptying of solid meal
AU2001243965A AU2001243965A1 (en) 2000-03-27 2001-03-26 Gastric emptying test-kit and method of testing gastric emptying of solid meal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0007315A GB2360845A (en) 2000-03-27 2000-03-27 Measuring gastric emptying

Publications (2)

Publication Number Publication Date
GB0007315D0 GB0007315D0 (en) 2000-05-17
GB2360845A true GB2360845A (en) 2001-10-03

Family

ID=9888439

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0007315A Withdrawn GB2360845A (en) 2000-03-27 2000-03-27 Measuring gastric emptying

Country Status (3)

Country Link
AU (1) AU2001243965A1 (en)
GB (1) GB2360845A (en)
WO (1) WO2001072342A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1707219A2 (en) 2005-04-01 2006-10-04 Atomic Energy Council - Institute of Nuclear Energy Research Radioactive kits for a gastric emptying measurement
WO2009152222A2 (en) * 2008-06-10 2009-12-17 Advanced Breath Diagnostics, Llc Fluid bed meal containing a marker and methods of making
US7785569B2 (en) * 2002-05-10 2010-08-31 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
US8178315B2 (en) 2002-05-10 2012-05-15 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker and methods of making
US8231530B2 (en) 2007-05-10 2012-07-31 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
US8317718B2 (en) 2007-05-10 2012-11-27 Advanced Breath Diagnostics, Llc Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
US10772534B2 (en) 2013-03-13 2020-09-15 Advanced Breath Diagnostics, Llc Single-point gastric emptying breath tests

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338444B2 (en) 2002-06-28 2008-03-04 Oridion Breathid Ltd Management of gastro-intestinal disorders
WO2004002307A2 (en) * 2002-06-28 2004-01-08 Oridion Breathid Ltd. Management of gastro-intestinal disorders
EP1901779A2 (en) * 2005-07-12 2008-03-26 The Leeds Teaching Hospitals NHS Trust Measurement of gastric acid secretion
CN108624516B (en) * 2017-03-20 2022-08-26 华东理工大学 Method for improving metabolite amount in fermentation cells and preparing IDMS standard substance

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035622A1 (en) * 1996-03-25 1997-10-02 Meretek Diagnostics Measurement of gastric emptying
WO2000061197A1 (en) * 1999-04-09 2000-10-19 Phenome Sciences Inc. Assessment of gastric emptying disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785949A (en) * 1996-09-05 1998-07-28 Meretek Diagnostics Measurement of liquid phase gastric emptying

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035622A1 (en) * 1996-03-25 1997-10-02 Meretek Diagnostics Measurement of gastric emptying
WO2000061197A1 (en) * 1999-04-09 2000-10-19 Phenome Sciences Inc. Assessment of gastric emptying disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts Accession No: 124:134616 & Dig. Dis. Sci.(1995), 40(10), pages 2200 - 2206. *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785569B2 (en) * 2002-05-10 2010-08-31 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker
US8178315B2 (en) 2002-05-10 2012-05-15 Advanced Breath Diagnostics, Llc Lyophilized edible food incorporating a marker and methods of making
EP1707219A2 (en) 2005-04-01 2006-10-04 Atomic Energy Council - Institute of Nuclear Energy Research Radioactive kits for a gastric emptying measurement
EP1707219A3 (en) * 2005-04-01 2007-11-07 Atomic Energy Council - Institute of Nuclear Energy Research Radioactive kits for a gastric emptying measurement
US8231530B2 (en) 2007-05-10 2012-07-31 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
US8317718B2 (en) 2007-05-10 2012-11-27 Advanced Breath Diagnostics, Llc Methods of testing digestive functions using both a breath test and a scintigraphy test, and methods of using a breath test as an overall digestive health assessment
US8388531B2 (en) 2007-05-10 2013-03-05 Advanced Breath Diagnostics, Llc Methods and systems for assessing gastric emptying
WO2009152222A2 (en) * 2008-06-10 2009-12-17 Advanced Breath Diagnostics, Llc Fluid bed meal containing a marker and methods of making
WO2009152222A3 (en) * 2008-06-10 2010-04-15 Advanced Breath Diagnostics, Llc Fluid bed meal containing a marker and methods of making
US8753609B2 (en) 2008-06-10 2014-06-17 Advanced Breathe Diagnostics, LLC Fluid bed meal containing a marker and methods of making
US10772534B2 (en) 2013-03-13 2020-09-15 Advanced Breath Diagnostics, Llc Single-point gastric emptying breath tests

Also Published As

Publication number Publication date
AU2001243965A1 (en) 2001-10-08
GB0007315D0 (en) 2000-05-17
WO2001072342A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU708697B2 (en) Measurement of gastric emptying
Koutsos et al. Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: A randomized, controlled, crossover trial
Braden et al. 13C-breath tests: current state of the art and future directions
Wutzke et al. The effect of l-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects
Knox et al. Calcium absorption in elderly subjects on high-and low-fiber diets: effect of gastric acidity
Kerlin et al. Rice flour, breath hydrogen, and malabsorption
EP0928204B1 (en) Measurement of liquid phase gastric emptying
Crapo et al. Comparison of the metabolic responses to fructose and sucrose sweetened foods
Tadesse et al. Breath hydrogen (H2) and methane (CH4) excretion patterns in normal man and in clinical practice
GB2360845A (en) Measuring gastric emptying
Dahlstrom et al. Serum trace elements in children receiving long-term parenteral nutrition
van Dijk-van Aalst et al. 13 C Mixed Triglyceride Breath Test: A Noninvasive Method to Assess Lipase Activity in Children
US6548043B1 (en) Measurement of gastric emptying
Egan et al. Zinc absorption in women: comparison of intrinsic and extrinsic stable-isotope labels
AU2003232099B2 (en) Lyophilized edible food incorporating a marker
Montes et al. Lactose intolerance: pinpointing the source of nonspecific gastrointestinal symptoms
Wutzke et al. Triglyceride oxidation in cystic fibrosis: a comparison between different 13C-labeled tracer substances
Berlyne et al. A soluble glucose polymer for use in renal failure and calorie-deprivation states
US20070014718A1 (en) Kits for gastric emptying measurement
Glasgow et al. A comprehensive study of duodenal bile salts in newborn infants and their relationship to fat absorption
Mishkin et al. Fructose and/or sorbitol intolerance in a subgroup of lactose intolerant patients
BR112021007021A2 (en) oral composition of galactose and its use
Test et al. REFERENCE METHOD AND VARIABILITY IN GASTRIC EMPTYING
Stone Blood Chemistry, Colorimetric Methods for the General Practitioner: With Clinical Comments and Dietary Suggestions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)